Skip to main content
Equibles
ACTU logo

ACTU · Actuate Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track ACTU — free

Use ACTU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACTU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.30 +0.01 (+1.75%) At close · Nov 11
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on the above matters, we have concluded that there is substantial doubt regarding the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$7.26M
Shares
24.01M
Volume · Nov 11 94.93K Avg daily vol (3M) 422.63K

Actuate Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Actuate Therapeutics, Inc. (ACTU), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)

No Webcasts Available

No webcast events are available for this stock yet.

Key facts CIK 1652935 CUSIP 005083100 13F (30d) 18 filings 18 filers Visit website Investor relations